May 25, 2025 – Cambridge, MA, and Bordeaux, France – inHEART, a medical device company specializing in AI-driven digital heart twin technology, is delighted to announce the appointment of Randy Jordan as the new Chairman of its Board of Directors. This strategic addition to inHEART's leadership team is expected to significantly reinforce the company's trajectory in transforming electrophysiology and cardiac care.

Randy Jordan, formerly Chief Revenue Officer at Circle Cardiovascular Imaging, brings over 25 years of experience in life sciences and healthcare software to inHEART, offering valuable knowledge that will help support the company as it enters its next phase of growth and innovation. He holds a Bachelor of Business Administration (BBA) and an International MBA, which have contributed to his understanding of business practices and global market dynamics. Throughout his career, Randy has worked in various startups and integrated life science companies, consistently taking on roles with international responsibilities that have equipped him with a deep understanding of the startup industry.

Notably, Randy Jordan's earliest experience in the electrophysiology (EP) field dates back to 2003 with CryoCath Technologies, a company at the forefront of cryoablation technology, acquired by Medtronic in 2008. This deep-rooted understanding of EP, combined with his software and life sciences background, positions him uniquely to contribute to inHEART's mission of revolutionizing cardiac arrhythmia treatment through precision digital twins.

In his new role, Randy will leverage his strategic vision to guide inHEART's executive team, refine its market strategies, and accelerate the adoption of its cutting-edge technology by cardiologists and electrophysiologists worldwide. His appointment underscores inHEART’s commitment to building a world-class leadership team dedicated to improving patient outcomes through technological innovation. “inHEART has been delivering world-class cardiac imaging expertise and treatment planning as a trusted partner to physicians and health systems to optimize treatment strategies, workflow and improve clinical outcomes. I am delighted to partner with the team and contribute to advancing the care for patients living with cardiac disease,” said Randy Jordan.

"We are incredibly excited to welcome Randy Jordan to our Board as Chairman," said Todor Jeliaskov, inHEART’s CEO. "Randy's proven leadership, deep industry expertise, and extensive experience in scaling innovative healthcare technologies will be invaluable as we continue to advance our AI-driven digital twin platform."

About inHEART

inHEART is delivering the world’s firstAI-driven, digital twin of the heart to advance the care of patients living with cardiac disease. We are committed to addressing the needs of the cardiac care continuum by providing personalized therapy in a predictive manner for screening and early detection of cardiac diseases. At inHEART, we believe that all patients deserve access to world-class cardiac imaging expertise to optimize treatment.